NAKI Therapeutics will be presenting at the upcoming BIO International Convention (June 13-16, 2022・San Diego Convention Center)

Management Team

Guanghui Hu, PhD

Chief Executive Officer

Read More

Don Liu, PhD

Chief Science Officer

Read More

Karl Pawlik

Chief Financial Officer

Read More

Azra Sadibasic

Operations Manager

Read More

ABOUT US

Company Overview
Management Team
Board of Directors
Scientific Advisory Board

SCIENCE

CD147
Expansion Technology
Oncology / HCC

PUBLICATIONS

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells
Efficacy of anti-CD147

CONTACT US